U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
191041191041Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98CompletedNo Results AvailableOpen-Angle Glaucoma|Ocular HypertensionDrug: IOP Lowering Medicationshttps://ClinicalTrials.gov/show/NCT00047593
191042191042Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe SpastiCompletedNo Results AvailableMultiple Sclerosis|Muscle Spasticity|Spinal Cord Injury|StrokeDrug: tizanidine hydrochloride capsulehttps://ClinicalTrials.gov/show/NCT00047580
191043191043Open-Label Adjunctive Zonisamide for Bipolar DisorderTerminatedNo Results AvailableBipolar DisordersDrug: zonisamidehttps://ClinicalTrials.gov/show/NCT00047567
191044191044Study of TRAVATAN in Subjects With Iris Pigmentation ChangesTerminatedNo Results AvailableOpen-Angle Glaucoma|Ocular HypertensionDrug: Travoprost, 0.004% ophthalmic solutionhttps://ClinicalTrials.gov/show/NCT00047554
191045191045Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70CompletedNo Results AvailableOpen-Angle Glaucoma|Ocular HypertensionDrug: Alcon Investigational Agenthttps://ClinicalTrials.gov/show/NCT00047541
191046191046Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41CompletedNo Results AvailableOpen-Angle Glaucoma|Ocular HypertensionDrug: Alcon Investigational Agenthttps://ClinicalTrials.gov/show/NCT00047528
191047191047Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69CompletedNo Results AvailableOpen-Angle Glaucoma|Ocular HypertensionDrug: Alcon Investigational Agenthttps://ClinicalTrials.gov/show/NCT00047515
191048191048Study of Lonafarnib and Gleevec in Chronic Myelogenous LeukemiaCompletedNo Results AvailableChronic Myelogenous LeukemiaDrug: Lonafarnib (SCH66336)|Drug: Imatinib Mesylate (Gleevec)https://ClinicalTrials.gov/show/NCT00047502
191049191049Study of ABT-751 in Patients With Refractory Hematologic MalignanciesCompletedNo Results AvailableHematological MalignanciesDrug: ABT-751https://ClinicalTrials.gov/show/NCT00047489
191050191050D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer PatientsCompletedNo Results AvailableFatigue|NeoplasmsDrug: dexmethylphenidate(d-mph)https://ClinicalTrials.gov/show/NCT00047476
191051191051Effects of Treating Obstructive Sleep Apnea in EpilepsyCompletedHas ResultsEpilepsy|Sleep Apnea|Obstructive Sleep ApneaDevice: continuous positive airway pressure (CPAP)|Device: Placebo-CPAPhttps://ClinicalTrials.gov/show/NCT00047463
191052191052Antidepressant Treatment in Older Adults With SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: Citalopram (Celexa)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00047450
191053191053Exercise Training Program to Improve Clinical Outcomes in Individuals With Congestive Heart FailureCompletedNo Results AvailableCardiovascular Diseases|Heart Diseases|Heart Failure, CongestiveBehavioral: Supervised Exercise Training Programhttps://ClinicalTrials.gov/show/NCT00047437
191054191054Stop Atherosclerosis in Native Diabetics Study (SANDS)CompletedNo Results AvailableAtherosclerosis|Cardiovascular Diseases|Heart Diseases|Diabetes Mellitus|HypertensionDrug: simvastatin|Drug: ACE inhibitorshttps://ClinicalTrials.gov/show/NCT00047424
191055191055Home Use of Automatic External Defibrillators to Treat Sudden Cardiac ArrestCompletedNo Results AvailableCardiovascular Diseases|Myocardial Infarction|Heart Diseases|Death, Sudden, CardiacOther: Cardiopulmonary Resuscitation|Device: Automatic External Defibrillationhttps://ClinicalTrials.gov/show/NCT00047411
191056191056National Lung Screening Trial (NLST) ScreeningCompletedHas ResultsLung CancerDevice: low-dose helical computed tomography|Device: chest radiographyhttps://ClinicalTrials.gov/show/NCT00047385
191057191057Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver DysfunctionCompletedNo Results AvailableAdult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver CancerDrug: erlotinib hydrochloride|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00047346
191058191058Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically RemovedTerminatedNo Results AvailableAdult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver CancerDrug: erlotinib hydrochloride|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00047333
191059191059Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell TumorsActive, not recruitingHas ResultsBrain Tumor|Central Nervous System Tumors|Childhood Germ Cell TumorDrug: carboplatin|Drug: etoposide|Drug: ifosfamide|Drug: thiotepa|Procedure: adjuvant therapy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Procedure: peripheral blood stem cell transplantation|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00047320
191060191060Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic CancerCompletedNo Results AvailableAdenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic CancerDrug: alvocidib|Drug: gemcitabine hydrochloride|Radiation: 3-dimensional conformal radiation therapy|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00047307
191061191061Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeActive, not recruitingNo Results AvailableBrain and Central Nervous System TumorsDrug: celecoxib|Drug: temozolomide|Drug: thalidomide|Procedure: adjuvant therapyhttps://ClinicalTrials.gov/show/NCT00047294
191062191062Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant GliomaActive, not recruitingNo Results AvailableBrain and Central Nervous System TumorsDrug: celecoxib|Drug: cyclophosphamide|Drug: etoposide|Drug: thalidomidehttps://ClinicalTrials.gov/show/NCT00047281
191063191063Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic SyndromeActive, not recruitingNo Results AvailableLeukemia|Myelodysplastic/Myeloproliferative NeoplasmsDrug: cytarabine|Drug: mercaptopurine|Other: laboratory biomarker analysis|Procedure: allogeneic bone marrow transplantation|Procedure: biopsy|Procedure: peripheral blood stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00047268
191064191064Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast CancerCompletedNo Results AvailableBreast CancerBiological: trastuzumab|Drug: carboplatin|Drug: docetaxel|Biological: trastuxumab|Drug: Docetaxelhttps://ClinicalTrials.gov/show/NCT00047255
191065191065UCN-01 and Irinotecan in Treating Patients With Advanced Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: 7-hydroxystaurosporine|Drug: irinotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00047242
191066191066Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)CompletedNo Results AvailableLiver CancerBiological: oblimersen sodium|Drug: doxorubicin hydrochloridehttps://ClinicalTrials.gov/show/NCT00047229
191067191067Tipifarnib in Treating Patients With Recurrent Bladder CancerCompletedNo Results AvailableBladder CancerDrug: tipifarnibhttps://ClinicalTrials.gov/show/NCT00047216
191068191068Flavopiridol in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNo Results AvailableRefractory Multiple Myeloma|Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple MyelomaDrug: alvocidibhttps://ClinicalTrials.gov/show/NCT00047203
191069191069Tipifarnib in Treating Patients With Myelofibrosis and Myeloid MetaplasiaCompletedNo Results AvailableEssential Thrombocythemia|Polycythemia Vera|Primary MyelofibrosisDrug: tipifarnib|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00047190
191070191070Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid TumorCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: Oxaliplatinhttps://ClinicalTrials.gov/show/NCT00047177

* Görseller ve İçerik tekif hakkına sahip olabilir